IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and InfectionSummary

• Main Authors: Jon N. Buzzelli, Heather V. Chalinor, Daniel I. Pavlic, Philip Sutton, Trevelyan R. Menheniott, Andrew S. Giraud, Louise M. Judd
• Format: Article
• Language: English
• Published: Elsevier 2015-03-01
• Series: Cellular and Molecular Gastroenterology and Hepatology
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352345X14000137

Background & Aims: Interleukin (IL)33 is a recently described alarmin that is highly expressed in the gastric mucosa and potently activates Th2 immunity. It may play a pivotal role during Helicobacter pylori infection. Here, we delineate the role of IL33 in the normal gastric mucosa and in response to gastropathy. Methods: IL33 expression was evaluated in mice and human biopsy specimens infected with H pylori and in mice after dosing with aspirin. IL33 expression was localized in the gastric mucosa using immunofluorescence. Mice were given 1 or 7 daily doses of recombinant IL33 (1 μg/dose), and the stomach and the spleen responses were quantified morphologically, by flow cytometry and using quantitative reverse-transcription polymerase chain reaction and immunoblotting. Results: In mice, the IL33 protein was localized to the nucleus of a subpopulation of surface mucus cells, and co-localized with the surface mucus cell markers Ulex Europaeus 1 (UEA1), and Mucin 5AC (Muc5AC). A small proportion of IL33-positive epithelial cells also were Ki-67 positive. IL33 and its receptor Interleukin 1 receptor-like 1 (ST2) were increased 4-fold after acute (1-day) H pylori infection, however, this increase was not apparent after 7 days and IL33 expression was reduced 2-fold after 2 months. Similarly, human biopsy specimens positive for H pylori had a reduced IL33 expression. Chronic IL33 treatment in mice caused systemic activation of innate lymphoid cell 2 and polarization of macrophages to the M2 phenotype. In the stomach, IL33-treated mice developed transmural inflammation and mucous metaplasia that was mediated by Th2/signal transducer and activator of transcription 3 signaling. Rag-1-/- mice, lacking mature lymphocytes, were protected from IL33-induced gastric pathology. Conclusions: IL33 is highly expressed in the gastric mucosa and promotes the activation of T helper 2âcytokineâexpressing cells. The loss of IL33 expression after prolonged H pylori infection may be permissive for the T helper 1âbiased immune response observed during H pylori infection and subsequent precancerous progression. Keywords: IL33, Helicobacter pylori, Inflammatory Response, Gastric Cancer